Cardiomyopathy Stocks List

Recent Signals

Date Stock Signal Type
2021-05-11 APLT 20 DMA Resistance Bearish
2021-05-11 APLT Slingshot Bearish Bearish Swing Setup
2021-05-11 BBIO Stochastic Buy Signal Bullish
2021-05-11 BBIO Slingshot Bearish Bearish Swing Setup
2021-05-11 BBIO Lower Bollinger Band Walk Weakness
2021-05-11 BBIO Bullish Engulfing Bullish
2021-05-11 CYCN Calm After Storm Range Contraction
2021-05-11 CYCN 20 DMA Support Bullish
2021-05-11 DRNA MACD Bearish Centerline Cross Bearish
2021-05-11 DRNA 50 DMA Resistance Bearish
2021-05-11 DRNA Bullish Engulfing Bullish
2021-05-11 DRNA Stochastic Buy Signal Bullish
2021-05-11 IONS Slingshot Bearish Bearish Swing Setup
2021-05-11 IONS Lower Bollinger Band Walk Weakness
2021-05-11 IONS Bullish Engulfing Bullish
2021-05-11 IONS New 52 Week Low Weakness
2021-05-11 VCEL Lower Bollinger Band Walk Weakness

Recent News for Cardiomyopathy Stocks

Date Stock Title
May 12 IONS Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat
May 11 DRNA Goldman Sachs Says These 3 Stocks Could Surge Over 70% From Current Levels
May 11 APLT Applied Therapeutics EPS beats by $0.10
May 11 APLT Applied Therapeutics Reports First Quarter 2021 Financial Results
May 11 DRNA Dicerna A Buy On Long-Term Potential
May 10 DRNA Dicerna Pharmaceuticals (NASDAQ:DRNA) Is In A Strong Position To Grow Its Business
May 9 CYCN The CEO & Director of Cyclerion Therapeutics, Inc. (NASDAQ:CYCN), Peter Hecht, Just Bought 309% More Shares
May 8 CYCN The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics And More
May 8 DRNA Dicerna Pharmaceuticals (DRNA) CEO Doug Fambrough on Q1 2021 Results - Earnings Call Transcript
May 7 DRNA Dicerna Pharmaceuticals Inc (DRNA) Q1 2021 Earnings Call Transcript
May 6 DRNA Dicerna Pharmaceuticals (DRNA) Reports Q1 Loss, Lags Revenue Estimates
May 6 DRNA Dicerna posts 40% jump in Q1 revenue, gives cash position update
May 6 DRNA Dicerna Pharmaceuticals EPS misses by $0.02, misses on revenue
May 6 DRNA Dicerna Announces First Quarter 2021 Financial Results and Provides a Business Update
May 6 DRNA Dicerna Pharmaceuticals, Inc. to Host Earnings Call
May 6 IONS Ionis (IONS) Q1 Loss Widens Year Over Year, Sales Miss
May 6 BBIO BridgeBio Pharma (BBIO) Reports Q1 Loss, Lags Revenue Estimates
May 6 BBIO BridgeBio Pharma EPS misses by $0.37
May 6 BBIO BridgeBio Pharma, Inc. Reports First Quarter 2021 Financial Results And Business Update
May 6 VCEL Vericel (VCEL) Q1 2021 Earnings Call Transcript
Related Industries: Biotechnology

Cardiomyopathy is a group of diseases that affect the heart muscle. Early on there may be few or no symptoms. Some people may have shortness of breath, feel tired, or have swelling of the legs due to heart failure. An irregular heart beat may occur as well as fainting. Those affected are at an increased risk of sudden cardiac death.Types of cardiomyopathy include hypertrophic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, arrhythmogenic right ventricular dysplasia, and takotsubo cardiomyopathy (broken heart syndrome). In hypertrophic cardiomyopathy the heart muscle enlarges and thickens. In dilated cardiomyopathy the ventricles enlarge and weaken. In restrictive cardiomyopathy the ventricle stiffens.The cause is frequently unknown. Hypertrophic cardiomyopathy usually is inherited, while dilated cardiomyopathy is inherited in a third of cases. Dilated cardiomyopathy may also result from alcohol, heavy metals, coronary heart disease, cocaine use, and viral infections. Restrictive cardiomyopathy may be caused by amyloidosis, hemochromatosis, and some cancer treatments. Broken heart syndrome is caused by extreme emotional or physical stress.Treatment depends on the type of cardiomyopathy and the severity of symptoms. Treatments may include lifestyle changes, medications, or surgery. In 2015 cardiomyopathy and myocarditis affected 2.5 million people. Hypertrophic cardiomyopathy affects about 1 in 500 people while dilated cardiomyopathy affects 1 in 2,500. They resulted in 354,000 deaths up from 294,000 in 1990. Arrhythmogenic right ventricular dysplasia is more common in young people.

More about Cardiomyopathy
Browse All Tags